Atlas Trials

Efficacy and Safety of Intravitreal Aflibercept Injection for Subacute Central Serous Chorioretinopathy

Clinical trial NCT01971190 · COMPLETED

Trial details

NCT number
NCT01971190
Sponsor
Asan Medical Center
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Central Serous Chorioretinopathy
Start date
2013-10-01
Primary completion
2015-04-01
Enrollment
43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.